Plain-English translation of NCT05305066 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether doctors can use blood tests, genetic information, and advanced computer predictions to figure out which biologic medication — such as etanercept, adalimumab, tocilizumab, or tofacitinib — will work best for your rheumatoid arthritis. Right now, doctors try different medications one at a time, which can take months or years. This research aims to predict which treatment will help you faster and more accurately.
Rheumatoid arthritis is a serious disease that causes joint damage and affects mostly women during their most productive years. Even though many biologic medications are available, about 30% of patients don't respond to any particular drug, and doctors have no reliable way to predict which one will work for each person. This trial exists to solve that problem by finding a smarter way to match patients with the right medication from the start.
You likely qualify if…
You likely don't qualify if…
You would join one of two study groups depending on your treatment history. In both groups, you would start taking one of the biologic medications being tested (given by injection or pill). Before and during treatment, researchers would collect blood samples to analyze your genes, immune markers, and other biological information. This data would help doctors understand why certain medications work better for certain patients, with the goal of improving treatment predictions for future patients with rheumatoid arthritis.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Canada